How to Win!
Over the past 22 years we have learned how to beat the insurance companies and maximize our clients recoveries. We amass a legal team! We combined our successful talents and expertise with that of other top trial attorneys from around the country to give you a legal team with proven success for the same cost as having one lawyer.We Fight and You Win.
Results!
We have represented over 10,000 clients and recovered millions of dollars on their behalf. We take each case seriously. We are paid only when you get results!Here are just some of our successses
Free Legal Consultations.
Our personal injury lawyer team provides you with a legal consultation at no cost to ensure you know what to expect. If you have recently been in injured, caused by the negligence of another, consult with an attorney now.
Medical Malpractice
Mistakes caused by medical malpractice can be both traumatic and confusing. Often, there is little or no recourse for victims of medical malpractice or their families. We will vigorously investigate your claim. Contact an attorney to ensure your rights are protected.
Vioxx Injuries
The arthritis drug Vioxx, manufactured by Merck & Co., was recently pulled from the market because of data showing increased risk of heart attack and stroke associated with the drug. If you or someone you know have has a stroke or heart attack that may be related to the prescription drug Vioxx, consult with an attorney.
Nursing Home Abuse
We all want to be able to trust that our loved ones are safe and cared for when residing in a nursing home, but we have to watch out for signs of neglect or abuse. Consult with an attorney if you suspect mistreatment of a nursing home resident.
Drug Litigation
Prescription pharmaceuticals are often available to the public before potential risks are discovered. If you believe you are the victim of a dangerous prescription drug, consult with a drug litigation attorney.
Personal Injury News
- Confusion between Maalox Brand Products May Lead to Serious Medical Errors Recently, the FDA notified consumers and healthcare professionals about reports of serious medical errors where patients had mistakenly used Maalox Total Relief, when they intended to use a Maalox liquid antacid. Both products are available without a prescription, but are not interchangeable. Consumers were confusing traditional Maalox with Maalox Total Relief, an anti-diarrhea medication that contains strong drug ingredients which may cause internal bleeding. Traditional Maalox uses a gentler formula which helps neutralize stomach acid. Due to the confusion, Novartis, the manufacturer of Maalox, has agreed to change the name and packaging of the potent medication Maalox Total Relief. The FDA has announced that children and teenagers recovering from illness should not take the higher-strength Maalox. The higher-strength Maalox can also negatively interact with certain medications, such as oral antidiabetic drugs, anti-inflammatory drugs like aspirin, and the blood thinners ....
- Residents of Nursing Home Go Clubbing as Biker Gang Nursing home residents at Bethesda Retirement Center in Chicago usually spend their time knitting or quilting. One day, they decided to try something different, and headed out to Evil Olive nightclub dressed as a biker gang. After recruiting hairstylists, make-up artists, professional costumers and tattoo artists, the seniors got transformed for their night of fun. The event at the Evil Olive was attended by over 100 people, including members of the Latino American Motorcycle Association and Chicago’s Chapter of A.B.A.T.E. The nursing home residents were even able to raise money to help purchase a touch screen computer for the retirement center for internet use. ....
- Newly Uncovered Reports Indicate FDA Debate over Avandia Heating Up Avandia, a popular drug used to treat Type 2 diabetes, has been linked to a higher risk of heart attack and heart failure than any other diabetes drug. The drug has recently made headlines due to the uncovering of confidential government reports, in which doctors from the Food and Drug Administration concluded that “Rosiglitazone [Avandia] should be removed from the market.” The uncovered reports are part of an intense debate over whether the federal agency should withdraw Avandia from the market. The debate has also been fueled by disagreements over a new clinical trial on the risks of Avandia and a Senate investigation which concluded that Avandia’s manufacturer, GlaxoSmithKline, should have warned patients about its risks years earlier. As Senator Baucus, a Montana Democrat who oversaw the Senate advisory committee on Avandia stated, “Patients trust drug companies with their health and their lives, and GlaxoSmithKline abused that trust.” At one time, ....
- New Study Finds Overuse of Feeding Tubes in Advanced Dementia Patients A new study in the Journal of the American Medical Association (JAMA) finds that the decision to give patients with advanced dementia feeding tubes depends more on cost concerns than the patient’s well-being. Hundreds of patients surveyed by Dr. Joan Teno of Brown University were given a feeding tube although they had specified in writing that they did not want one. Feeding tubes do not increase survival for people with dementia who can no longer swallow. Rather, they can cause harm as demented patients often try to remove them, and are then consequently physically restrained or placed on heavy sedatives. Dementia is receiving more recognition as a terminal illness. Trouble eating indicates the arrival of the final stage of the illness, and careful hand feeding can provide the patient with a safer and more comfortable alternative than a feeding tube. However, feeding by hand requires a lot of time and effort. Cost concerns are likely a significant factor in the large use of ....
- Cognis and Teligen Defibrillators May Have Deadly Defect According to a recent article in the journal HeartRhythm, Boston Scientific Corp’s Cognis and Teligen brand defibrillators have a dangerous design flaw. Defibrillators are portable electronic devices that automatically diagnose possibly life-threatening irregular heart rhythms in a patient, and help the heart re-establish effective rhythm with the application of electrical therapy. The defect in the Cognis and Teligen defibrillators by Boston Scientific may cause the devices to deliver unnecessary and life-threatening shocks to patients, and may affect the 90,000 patients who have the devices. In December 2009, Boston Scientific reported the cases of two patients where the defibrillator that connects the device to the heart became loose. In January 2010, Boston Scientific stated the problem was fixed, and that the defect was limited to patients with defibrillators implanted under their chest muscles. However, HeartRhythm reported that Boston Scientific received at least ....
The information provided does not constitute legal advice nor does it constitute an attorney client agreement. You are not considered a client until we have accepted your case and a retainer is signed. Read our full disclaimer.